ReviewVeterinary sciences2026
Epigenetic and Epitranscriptomic Regulation of Mastitis in Dairy Cattle: A Review.
Review in Veterinary sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Mastitis remains the most economically damaging disease in the global dairy industry, and conventional genetic selection based on somatic cell score (SCS) has produced only limited gains in resistance. Epigenetic mechanisms-mitotically heritable yet environmentally responsive and largely reversible modifications that regulate gene expression without altering the DNA sequence-are now emerging as a complementary layer of biological information that can sharpen the prediction of disease susceptibility. This review summarizes current evidence on three classes of epigenetic markers associated with bovine mastitis resistance: DNA methylation, non-coding RNAs (with emphasis on microRNAs, long non-coding RNAs, circular RNAs, and small nucleolar RNAs), and histone modifications, alongside the increasingly important epitranscriptomic layer of N6-methyladenosine (m6A) RNA modification. Particular attention is given to differentially methylated regions and discriminant methylation haplotype blocks in immune-related genes, circulating and milk-derived non-coding RNA biomarkers, m6A-mediated regulation of inflammatory transcripts, and histone-mark dynamics in mammary epithelial cells challenged with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.